|
|
|
Volumn 15, Issue 3, 2001, Pages 174-
|
|
Phase III trials for new PI.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ABACAVIR;
AMPRENAVIR;
AMPRENAVIR PHOSPHATE;
CARBAMIC ACID DERIVATIVE;
LAMIVUDINE;
NELFINAVIR;
ORGANOPHOSPHATE;
PRODRUG;
PROTEINASE INHIBITOR;
SULFONAMIDE;
ARTICLE;
CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
METHODOLOGY;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CARBAMATES;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS, PHASE III;
DIDEOXYNUCLEOSIDES;
HIV PROTEASE INHIBITORS;
HUMANS;
LAMIVUDINE;
MULTICENTER STUDIES;
NELFINAVIR;
PHOSPHORIC ACID ESTERS;
PRODRUGS;
RANDOMIZED CONTROLLED TRIALS;
SULFONAMIDES;
|
|
EID: 0035291301
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|